Search Results - "Snijders, P. J"

Refine Results
  1. 1

    Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: A systematic review and meta-analysis of randomised trials by Verdoodt, F, Jentschke, M, Hillemanns, P, Racey, C.S, Snijders, P.J.F, Arbyn, M

    Published in European journal of cancer (1990) (01-11-2015)
    “…Abstract Introduction Population coverage for cervical cancer screening is an important determinant explaining differences in the incidence of cervical cancer…”
    Get full text
    Journal Article
  2. 2

    Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials by Rietbergen, M.M., Brakenhoff, R.H., Bloemena, E., Witte, B.I., Snijders, P.J.F., Heideman, D.A.M., Boon, D., Koljenovic, S., Baatenburg-de Jong, R.J., Leemans, C.R.

    Published in Annals of oncology (01-11-2013)
    “…The presence of human papillomavirus (HPV)-infection in oropharyngeal squamous cell carcinoma (OPSCC) is a major determinant in prognostic risk modeling…”
    Get full text
    Journal Article
  3. 3

    Clinical Validation of the cobas 4800 HPV Test for Cervical Screening Purposes by HEIDEMAN, D. A. M, HESSELINK, A. T, BERKHOF, J, VAN KEMENADE, F, MELCHERS, W. J. G, FRANSEN DAALMEIJER, N, VERKUIJTEN, M, MEIJER, C. J. L. M, SNIJDERS, P. J. F

    Published in Journal of Clinical Microbiology (01-11-2011)
    “…OA  Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+…”
    Get full text
    Journal Article
  4. 4

    Cervical cancer screening: on the way to a shift from cytology to full molecular screening by Dijkstra, M.G., Snijders, P.J.F., Arbyn, M., Rijkaart, D.C., Berkhof, J., Meijer, C.J.L.M.

    Published in Annals of oncology (01-05-2014)
    “…Cytology-based nation-wide cervical screening has led to a substantial reduction of the incidence of cervical cancer in western countries. However, the…”
    Get full text
    Journal Article
  5. 5

    Penile cancer: epidemiology, pathogenesis and prevention by Bleeker, M. C. G., Heideman, D. A. M., Snijders, P. J. F., Horenblas, S., Dillner, J., Meijer, C. J. L. M.

    Published in World journal of urology (01-04-2009)
    “…Objectives Penile cancer is a disease with a high morbidity and mortality. Its prevalence is relatively rare, but the highest in some developing countries…”
    Get full text
    Journal Article
  6. 6

    The Aptima HPV Assay Fulfills the Cross-Sectional Clinical and Reproducibility Criteria of International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening by Heideman, D A M, Hesselink, A T, van Kemenade, F J, Iftner, T, Berkhof, J, Topal, F, Agard, D, Meijer, C J L M, Snijders, P J F

    Published in Journal of Clinical Microbiology (01-11-2013)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  7. 7

    Methylation marker analysis of self‐sampled cervico‐vaginal lavage specimens to triage high‐risk HPV‐positive women for colposcopy by Hesselink, A.T., Heideman, D.A.M., Steenbergen, R.D.M., Gök, M., van Kemenade, F.J., Wilting, S.M., Berkhof, J., Meijer, C.J.L.M., Snijders, P.J.F.

    Published in International journal of cancer (15-08-2014)
    “…Methylation markers were studied for their suitability to triage human papillomavirus (HPV)‐positive women by testing self‐collected cervico‐vaginal lavage…”
    Get full text
    Journal Article
  8. 8

    Clinical Validation of the Abbott RealTime High Risk HPV Assay According to the Guidelines for Human Papillomavirus DNA Test Requirements for Cervical Screening by Hesselink, A T, Meijer, C J L M, Poljak, M, Berkhof, J, van Kemenade, F J, van der Salm, M L, Bogaarts, M, Snijders, P J F, Heideman, D A M

    Published in Journal of Clinical Microbiology (01-07-2013)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  9. 9

    High-risk HPV type-specific clearance rates in cervical screening by BULKMANS, N. W. J, BERKHOF, J, BULK, S, BLEEKER, M. C. G, VAN KEMENADE, F. J, ROZENDAAL, L, SNIJDERS, P. J. F, MEIJER, C. J. L. M

    Published in British journal of cancer (07-05-2007)
    “…We assessed clearance rates of 14 high-risk human papillomavirus (hrHPV) types in hrHPV-positive women with normal cytology and borderline/mild dyskaryosis…”
    Get full text
    Journal Article Web Resource
  10. 10

    Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus by SMEETS, S. J, BRAAKHUIS, B. J. M, ABBAS, S, SNIJDERS, P. J. F, YLSTRA, B, VAN DE WIEL, M. A, MEIJER, G. A, LEEMANS, C. R, BRAKENHOFF, R. H

    Published in Oncogene (20-04-2006)
    “…Oncogene-expressing human papillomavirus type 16 (HPV16) is found in a subset of head and neck squamous cell carcinomas (HNSCC). HPV16 drives carcinogenesis by…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study by Uijterwaal, M H, Witte, B I, Van Kemenade, F J, Rijkaart, D, Ridder, R, Berkhof, J, Balfoort-van der Meij, G A M A, Bleeker, M C G, Snijders, P J F, Meijer, C J L M

    Published in British journal of cancer (18-03-2014)
    “…Background: Women with borderline/mildly dyskaryotic (BMD) cytology smears are currently followed up with repeat testing at 6 and 18 months. The objective of…”
    Get full text
    Journal Article
  13. 13

    Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study by LI, L. K, DAI, M, FRANCESCHI, S, CLIFFORD, G. M, YAO, W. Q, ARSLAN, A, LI, N, SHI, J. F, SNIJDERS, P. J. F, MEIJER, C. J. L. M, QIAO, Y. L

    Published in British journal of cancer (04-12-2006)
    “…To investigate the prevalence of, and risk factors for, cervical infection with human papillomavirus (HPV) in Shenyang City, People's Republic of China, we…”
    Get full text
    Journal Article
  14. 14

    Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study by DAI, M, BAO, Y. P, FRANCESCHI, S, LI, N, CLIFFORD, G. M, VACCARELLA, S, SNIJDERS, P. J. F, HUANG, R. D, SUN, L. X, MEIJER, C. J. L. M, QIAO, Y. L

    Published in British journal of cancer (03-07-2006)
    “…To investigate the prevalence of, and risk factors for, cervical infection with human papillomavirus (HPV) in the rural province of Shanxi, People's Republic…”
    Get full text
    Journal Article
  15. 15

    Human papillomavirus infection in women with and without cervical cancer in Karachi, Pakistan by Raza, S A, Franceschi, S, Pallardy, S, Malik, F R, Avan, B I, Zafar, A, Ali, S H, Pervez, S, Serajuddaula, S, Snijders, P J F, van Kemenade, F J, Meijer, C J L M, Shershah, S, Clifford, G M

    Published in British journal of cancer (25-05-2010)
    “…Background: No data exist on the population prevalence of, or risk factors for, human papillomavirus (HPV) infection in predominantly Muslim countries in Asia…”
    Get full text
    Journal Article
  16. 16

    Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening by Coupé, V M H, Berkhof, J, Bulkmans, N W J, Snijders, P J F, Meijer, C J L M

    Published in British journal of cancer (12-02-2008)
    “…We determined the prevalence of type-specific hrHPV infections in the Netherlands on cervical scrapes of 45 362 women aged 18–65 years. The overall hrHPV…”
    Get full text
    Journal Article
  17. 17

    Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control by Geraets, D T, Cuschieri, K, de Koning, M N C, van Doorn, L J, Snijders, P J F, Meijer, C J L M, Quint, W G V, Arbyn, M

    Published in Journal of clinical microbiology (01-11-2014)
    “…The LMNX genotyping kit HPV GP (LMNX) is based on the clinically validated GP5+/6+ PCR, with a genotyping readout as an alternative for the more established…”
    Get full text
    Journal Article
  18. 18

    Sequential gene promoter methylation during HPV-induced cervical carcinogenesis by HENKEN, F. E, WILTING, S. M, OVERMEER, R. M, VAN RIETSCHOTEN, J. G. I, NYGREN, A. O. H, ERRAMI, A, SCHOUTEN, J. P, MEIJER, C. J. L. M, SNIJDERS, P. J. F, STEENBERGEN, R. D. M

    Published in British journal of cancer (19-11-2007)
    “…We aimed to link DNA methylation events occurring in cervical carcinomas to distinct stages of HPV-induced transformation. Methylation specific-multiplex…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Comparison of the Clinical Performance of PapilloCheck Human Papillomavirus Detection with That of the GP5+/6+-PCR-Enzyme Immunoassay in Population-Based Cervical Screening by Hesselink, A.T, Heideman, D.A.M, Berkhof, J, Topal, F, Pol, R.P, Meijer, C.J.L.M, Snijders, P.J.F

    Published in Journal of Clinical Microbiology (01-03-2010)
    “…We compared the clinical performance of the PapilloCheck human papillomavirus (HPV) assay with that of the GP5+/6+-PCR method with an enzyme immunoassay…”
    Get full text
    Journal Article